Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE1, PHASE2
Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Condition: Safety Issues, Efficacy, MTD
NCT06141109
Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.